
Benzinga Pro data, Precision BioSciences (NASDAQ:DTIL) reported Q1 sales of $3.32 million. Earnings fell to a loss of $28.17 million, resulting in a 26.37% decrease from last quarter. Precision BioSciences collected $6.34 million in revenue during Q4, but reported earnings showed a $22.29 million loss.